Opening a drugstore and entering the Category 3 pharmaceuticals market
First written in FY2018. 2 of 4 entries say "Advanced", first in FY2019. Latest entry: FY2020-Q1.
The whole theme swung hardest in 2019: 1 of 6 companies on the "Worse" side.
2 other companies' latest entry also says "Advanced".
- FY2020-Q1AdvancedAnnual report
「On 1 September 2019, the company acquired the mail-order business for OTC Kampo products from 日本ヘルスケアアドバイザーズ and worked to absorb expertise in selling pharmaceuticals such as Kampo medicines and generate synergies.」
The pharmaceuticals business has progressed from conventional drugstore and drug sales to acquiring a mail-order business for OTC Kampo medicines, absorbing its sales expertise and creating synergies. - FY2019AdvancedAnnual report
「The company has newly begun handling pharmaceuticals including the Category 3 pharmaceutical “ティアホワイト” and the Category 2 pharmaceutical “防風通聖散,”」
The business has progressed from entering the drugstore and Class 3 OTC drug markets to beginning to handle drugs including Class 2 OTC drugs. - FY2019-Q2RestatedAnnual report
「The company develops products centered on supplements such as “チョウ活宣言®活性フローラ” and the Category 3 pharmaceutical “ティアホワイト,” as well as the basic skincare product “ｔｅａｔｅａ（ティアティア）,”」
The company continues to expand its health- and beauty-related products, including the Category 3 pharmaceutical “ティアホワイト.” - FY2018First statedAnnual report
「May 2018: Opened the drugstore “ティーライフのくすり屋 本店” and began selling the Category 3 pharmaceutical “ティアホワイト”」
The company records for the first time, as an independent business initiative, the opening of a drugstore and the start of sales of Category 3 pharmaceuticals.